Policy Blog – May 23, 2025 – House Bill Moves to Restore Immediate R&D Expensing — A Critical Step Forward
The reconciliation bill passed by the House this week includes a fix Life Science Washington and many others in our industry have been advocating for: restoring immediate expensing for R&D costs. Since the change to Section 174 of the tax code took effect in 2022, companies have been required to amortize R&D expenses over five […]